| scholarly article | Q13442814 |
| P50 | author | Gérard Friedlander | Q39659602 |
| P2093 | author name string | F Terzi | |
| P Briand | |||
| P Federici | |||
| G Grimber | |||
| M Burtin | |||
| M Hekmati | |||
| P2860 | cites work | Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype | Q28509173 |
| Epidermal growth factor receptor expression is abnormal in murine polycystic kidney | Q28510252 | ||
| Multiple positive and negative regulators of signaling by the EGF-receptor | Q33597396 | ||
| Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium | Q33597644 | ||
| Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice | Q34140717 | ||
| Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. | Q34341740 | ||
| Early role of Fsp1 in epithelial-mesenchymal transformation | Q34445512 | ||
| Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure | Q34580512 | ||
| Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice | Q35786298 | ||
| Effects of epidermal growth factor on collagen synthesis by an epithelioid cell line derived from normal rat kidney | Q35811714 | ||
| Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys | Q35832710 | ||
| An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice | Q36232599 | ||
| Identification and characterization of a fibroblast marker: FSP1 | Q36382596 | ||
| Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia | Q36397797 | ||
| HMG-CoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture | Q36885797 | ||
| Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease | Q37378446 | ||
| Potential physiologic roles for epidermal growth factor in the kidney | Q37738853 | ||
| Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance | Q39790972 | ||
| A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats | Q39926230 | ||
| Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants | Q40653709 | ||
| A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization | Q40677644 | ||
| Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure | Q40789769 | ||
| Epidermal growth factor and the kidney | Q40876362 | ||
| Osteopontin regulation in cultured rat renal epithelial cells | Q41107943 | ||
| Mechanisms of recovery from mechanical injury of renal tubular epithelial cells | Q41449763 | ||
| Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? | Q41667549 | ||
| Early molecular mechanisms in the progression of renal failure: role of growth factors and protooncogenes | Q41743379 | ||
| Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy | Q41919771 | ||
| Normal tubular regeneration and differentiation of the post-ischemic kidney in mice lacking vimentin. | Q42059569 | ||
| EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. | Q42510124 | ||
| Renal tubular cells are potential targets for epidermal growth factor | Q43585904 | ||
| Expression of epidermal growth factor in the rat kidney. An immunocytochemical and in situ hybridization study. | Q43744071 | ||
| Transient increase in renal epidermal growth factor content after unilateral nephrectomy in the mouse | Q46177717 | ||
| Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor | Q46766121 | ||
| The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase | Q48084939 | ||
| Pattern of expression of gamma-glutamyl transpeptidase in rat liver and kidney during development: study by immunochemistry and in situ hybridization. | Q53506982 | ||
| Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. | Q54471089 | ||
| Strain-dependent epithelial defects in mice lacking the EGF receptor | Q58326927 | ||
| Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model | Q67560073 | ||
| Segmental distribution of epidermal growth factor binding sites in rabbit nephron | Q68573417 | ||
| Epidermal growth factor is expressed by cells in the distal tubules during postnephrectomy renal growth | Q68820010 | ||
| Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity | Q68911965 | ||
| Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells | Q70146276 | ||
| Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression | Q71695873 | ||
| Reversal of lung lesions in transgenic transforming growth factor alpha mice by expression of mutant epidermal growth factor receptor | Q71701920 | ||
| Renal cysts in transgenic mice expressing transforming growth factor-alpha | Q72182430 | ||
| Subtotal nephrectomy: a mosaic of growth factors | Q72337333 | ||
| Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease | Q72564205 | ||
| Met -/- kidneys express epithelial cells that chemotax and form tubules in response to EGF receptor ligands | Q73281511 | ||
| Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism | Q73683729 | ||
| Subtotal nephrectomy alters tubular function: effect of phosphorus restriction | Q73961032 | ||
| Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis | Q77556038 | ||
| Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice | Q77726919 | ||
| The course of the remnant kidney model in mice | Q78016673 | ||
| Experimentally induced chronic renal insufficiency in the rat | Q79026802 | ||
| Sodium restriction decreases AP-1 activation after nephron reduction in the rat: role in the progression of renal lesions | Q95820930 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 225-234 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury | |
| P478 | volume | 106 |
| Q36663009 | A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms Tumor |
| Q37721284 | A conceptual framework for the molecular pathogenesis of progressive kidney disease. |
| Q43066733 | A look at transactivation of the EGF receptor by angiotensin II. |
| Q36386472 | A transcriptional network underlies susceptibility to kidney disease progression |
| Q85964497 | AKT2 is essential to maintain podocyte viability and function during chronic kidney disease |
| Q30319286 | Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? |
| Q40321378 | Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis |
| Q35897811 | Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis |
| Q33840576 | Acute kidney injury: a springboard for progression in chronic kidney disease |
| Q46616535 | Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach |
| Q33943997 | Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy |
| Q34559028 | Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling |
| Q28279068 | CSF-1 signaling mediates recovery from acute kidney injury |
| Q93203400 | Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and Gefitinib |
| Q38068098 | Chronic kidney disease following acute kidney injury-risk and outcomes |
| Q47379089 | Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation |
| Q37832642 | Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease |
| Q35188138 | Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy |
| Q47448214 | Deletion of the EGF receptor in vascular smooth muscle cells prevents chronic angiotensin II-induced arterial wall stiffening and media thickening |
| Q44185817 | Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice |
| Q44609775 | EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats |
| Q36677409 | EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease |
| Q64265796 | EGFR drives the progression of AKI to CKD through HIPK2 overexpression |
| Q33779193 | EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress |
| Q26796628 | EGFR signaling in renal fibrosis |
| Q35715849 | EGFR signaling promotes TGFβ-dependent renal fibrosis |
| Q37052016 | Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression |
| Q33814199 | Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System |
| Q35999532 | Epidermal growth factor activates Na(+/)H(+) exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin |
| Q45069263 | Epidermal growth factor receptor expression in human renal allograft biopsies: an immunohistochemical study. |
| Q33646704 | Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy |
| Q52913005 | Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis. |
| Q38763624 | Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney |
| Q37051477 | Epidermal growth factors in the kidney and relationship to hypertension. |
| Q48636743 | Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney. |
| Q91639633 | Four-jointed knock-out delays renal failure in an ADPKD model with kidney injury |
| Q92324811 | Gcm1 is involved in cell proliferation and fibrosis during kidney regeneration after ischemia-reperfusion injury |
| Q39472497 | Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells |
| Q39042077 | Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α. |
| Q35917468 | Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis. |
| Q40635030 | Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression |
| Q35791678 | Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction |
| Q42733192 | Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction |
| Q89355259 | Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes |
| Q40759373 | Integrin alpha1beta1 regulates epidermal growth factor receptor activation by controlling peroxisome proliferator-activated receptor gamma-dependent caveolin-1 expression |
| Q35919729 | JunD protects against chronic kidney disease by regulating paracrine mitogens. |
| Q34245315 | Lipocalin 2 is essential for chronic kidney disease progression in mice and humans |
| Q38409344 | Molecular evaluation of renal biopsies: a search for predictive and prognostic markers in lupus nephritis |
| Q36699821 | Necrotic renal epithelial cell inhibits renal interstitial fibroblast activation: role of protein tyrosine phosphatase 1B |
| Q53523828 | Opposing roles of EGF in IFN-alpha-induced epithelial barrier destabilization and tissue repair. |
| Q28572754 | Overexpression of kidney phosphatidylinositol 4-kinasebeta and phospholipase C(gamma1) proteins in two rodent models of polycystic kidney disease |
| Q35119033 | Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice |
| Q40845859 | Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells. |
| Q37688355 | Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis |
| Q90015597 | Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression |
| Q28345280 | Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions |
| Q35027277 | Protein-bound uremic toxins induce tissue remodeling by targeting the EGF receptor |
| Q35747935 | Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells |
| Q40743744 | Renal proximal tubular cell growth and differentiation are differentially modulated by renotropic growth factors and tyrosine kinase inhibitors |
| Q60935640 | Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage |
| Q40312801 | Role of TGF-alpha in the progression of diabetic kidney disease |
| Q36224457 | Role of epidermal growth factor receptor in acute and chronic kidney injury |
| Q36066400 | Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy |
| Q37190266 | Soluble HB-EGF induces epithelial-to-mesenchymal transition in inner medullary collecting duct cells by upregulating Snail-2. |
| Q30444037 | Species differences in renal Src activity direct EGF receptor regulation in life or death response to EGF. |
| Q41630808 | Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion |
| Q36027221 | Src family kinases regulate renal epithelial dedifferentiation through activation of EGFR/PI3K signaling |
| Q36777632 | Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis |
| Q27727718 | Structural basis of selectivity and neutralizing activity of a TGFα/epiregulin specific antibody |
| Q28482696 | Suramin alleviates glomerular injury and inflammation in the remnant kidney |
| Q35012404 | Suramin inhibits renal fibrosis in chronic kidney disease. |
| Q36986519 | Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury |
| Q34534909 | TGF-alpha mediates genetic susceptibility to chronic kidney disease. |
| Q37884486 | TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis |
| Q38259755 | Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. |
| Q38885079 | The epidermal growth factor receptor pathway in chronic kidney diseases |
| Q37126069 | The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology |
| Q82852643 | Tubular toxicity of proteinuria |
| Q38134341 | Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease. |
| Q52571164 | Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases. |
| Q37722852 | Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality |
| Q35588779 | WT1 and glomerular function. |
| Q40028539 | p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells |
| Q35679310 | β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors |
Search more.